Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|August 21, 2008
Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cellsDaniel Floryk, Timothy C Thompson
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 29, 2013
Patient enrollment onto clinical trials: the role of physician knowledgeJustin R Gregg, Leora Horn, Mario A Davidson, et al.
Cancer Management and Research|December 29, 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefitPaul G Corn, Timothy C Thompson
Science Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C Thompson
Cancer Biology & Therapy|November 20, 2009
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cellsSalahaldin A Tahir, Sanghee Park, Timothy C Thompson
Urology Practice|August 18, 2023
Recent Antibiotic Treatment Increases the Risk of Urinary Tract Infection after Outpatient CystoscopyJustin R Gregg, Caroline Lai, Roger Dmochowski, et al.
Schizophrenia Research|July 3, 2009
Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in ratsJustin R Gregg, Nicole R Herring, Alipi V Naydenov, et al.
Asian Journal of Urology|March 8, 2018
Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistanceStyliani Karanika, Theodoros Karantanos, Jianhua Yin, et al.
Nature Communications|August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Pageof 16